Cellebrite DI Ltd. - Ordinary Shares (CLBT)
Technology › Services-Prepackaged Software
Price History
Feb 9, 2026 — Mar 26, 2026Investment Snapshot
- Trading 282% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 16.2% — good return on equity
- Revenue growing at 19% annually
Cellebrite DI Ltd. - Ordinary Shares (CLBT) is a Technology company operating in Services-Prepackaged Software, listed on the NASDAQ , with a market capitalisation of $3.5 billion . Key value metrics: P/E ratio 45.1, P/B ratio 7.29, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cellebrite DI Ltd. - Ordinary Shares — Fundamental Analysis Summary
Cellebrite DI Ltd. - Ordinary Shares (CLBT) is currently trading 282% above its Graham Number of $3.70, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 45.1x.
On financial health, CLBT shows a moderate Piotroski F-Score of 4/9, and solid return on equity of 16.2% (sector average: -3.1%), and manageable leverage with a debt-to-equity ratio of 0.94.
StockPik's composite Value Score for CLBT is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CLBT reports a high gross margin of 84.2% (sector average: 41.3%) and a solid operating margin of 14.0%.
CLBT shows revenue growing at 19% year-over-year, with earnings growing at 128%.